AIDS/HIV. A reversal of fortune in HIV-1 integration.
Engelman
Alan
A
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA. alan_engelman@dfci.harvard.edu
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D045744:Cell Line, Tumor; D032621:DNA Shuffling; D019020:Directed Molecular Evolution; D015658:HIV Infections / Q000188:drug therapy; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D019426:Integrases / Q000235:genetics* / Q000378:metabolism*; D008213:Lymphocyte Activation; D011533:Proviruses / Q000378:metabolism / Q000502:physiology; D011995:Recombination, Genetic; D012091:Repetitive Sequences, Nucleic Acid; D016662:Virus Integration
C045073:Cre recombinase; D019426:Integrases